ArticleAnnals of translational medicine2023
PARP inhibitors, use early in the first-line maintenance therapy setting but with caution.
Elena Giudice et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2023
this papercites it